Table 1

Mean and SD of patients’ demographic and clinical baseline characteristics and their correlations with CDSS total scores at baseline (n = 198) and 12-month follow-up (n = 127)
Mean (SD) Correlation With CDSS total score at baseline (Pearson) Correlation with CDSS total score at12-month follow-up (Pearson)
Age 27.98 (8.70) 0.01 0.10
Gender (M) N = 127 (64%) 0.18* 0.13
Education (year) 12.71 (2.93) −0.02 −0.13
GAF symptom 41.12 (11.38) −0.29** −0.26**
GAF function 44.14 (12.65) −0.11 −0.22*
PANSS positive 12.95 (4.49) 0.07 0.06
PANSS negative 20.13 (7.72) 0.11 0.18*
PANSS excitative 8.07 (2.84) 0.21* −0.04
PANSS depressive 12.15 (3.61) 0.58** 0.37**
PANSS cognitive 5.38 (2.07) −0.004 0.06
PANSS-total score 63.38 (15.00) 0.27** 0.23*
PAS childhood social 2.51 (3.05) 0.26** 0.32**
PAS childhood academic 3.45 (2.43) 0.26** 0.26**
PAS early adolescence social 2.69 (2.88) 0.21** 0.22*
PAS early adolesc. academic 4.26 (2.75) 0.24* 0.17
DUPln 1.63 (0.80) 0.23** 0.30**
Insight (PANSS G12) 2.76 (1.36) −0.18* −0.11
AUDIT 7.76 (7.70) 0.17* 0.09
DUDIT 6.36 (9.58) 0.10 0.03
Anti-depressive medication day dosis 37.50 (35.75) 0.05 0.03
Anti-psychotic medication, day dosis 97.17 (155.88) −0.05 −0.07
CDSS total baseline 6.23 (4.44) -------------------- 0.48**

*Correlation is significant at the 0.05 level (2-tailed).

**Correlation is significant at the 0.01 level (2-tailed).

PANSS Positive and negative syndrome scale.

GAF Global assessment of functioning.

PAS Premorbid adjustment scale.

DUP Duration of untreated psychosis.

AUDIT Alcohol use disorders identification test.

DUDIT Drug use disorders identification test.

CDSS Calgary depression scale for schizophrenia.

Sönmez et al.

Sönmez et al. BMC Psychiatry 2013 13:106   doi:10.1186/1471-244X-13-106

Open Data